Back to Results
First PageMeta Content



PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   
Add to Reading List

Document Date: 2018-07-18 04:02:55


Open Document

File Size: 332,60 KB

Share Result on Facebook